Coronary artery apoptosis in experimental hypercholesterolemia.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 10030383)

Published in Atherosclerosis on February 01, 1999

Authors

D Hasdai1, G Sangiorgi, L G Spagnoli, R D Simari, D R Holmes, H M Kwon, P J Carlson, R S Schwartz, A Lerman

Author Affiliations

1: Division of Internal Medicine and Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA.

Articles by these authors

Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation (1995) 5.90

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation (2000) 5.53

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med (1981) 5.48

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med (1993) 4.56

Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation (1999) 4.14

Anomalous coronary arteries: location, degree of atherosclerosis and effect on survival--a report from the Coronary Artery Surgery Study. J Am Coll Cardiol (1989) 3.95

Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol (1992) 3.94

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82

Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci U S A (1999) 3.74

Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67

Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation (1997) 3.52

Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med (1967) 3.29

Racial profiling in medical research. N Engl J Med (2001) 3.25

The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med (1987) 3.17

Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med (1998) 3.04

Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87

Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J Immunol (1981) 2.83

Pathology of acute and chronic coronary stenting in humans. Circulation (1999) 2.78

Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77

Hybridoma autoantibodies to DNA. J Immunol (1980) 2.76

Jumping genes. N Engl J Med (1995) 2.69

Secular trends in coronary atherosclerosis--analysis in patients with valvular regurgitation. N Engl J Med (1996) 2.68

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65

Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med (2001) 2.54

Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest (1995) 2.53

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52

Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42

Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation (1997) 2.41

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38

Origins of anti-DNA autoantibodies. J Clin Invest (1985) 2.26

Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation (2001) 2.26

Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ (2006) 2.25

Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22

The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy. J Immunol (1965) 2.18

Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15

Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med (1973) 2.15

Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol (1998) 2.12

Underascertainment of child abuse mortality in the United States. JAMA (1999) 2.11

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med (1993) 2.09

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08

Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08

Coronary restenosis: prospects for solution and new perspectives from a porcine model. Mayo Clin Proc (1993) 2.06

Coronary artery fistulas: clinical consequences and methods of closure. A literature review. Ital Heart J (2001) 2.05

A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice. J Immunol (1982) 2.05

A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation (1993) 2.03

Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol (1997) 1.99

Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol (2001) 1.99

Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol (1999) 1.96

Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation (1994) 1.95

Permanent pacemaker infections: characterization and management. Am J Cardiol (1981) 1.95

Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity. J Biol Chem (1992) 1.93

Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder. Science (1965) 1.92

Clopidogrel versus ticlopidine after intracoronary stent placement. J Am Coll Cardiol (1999) 1.92

Management of balloon rupture during rigid stent deployment. Cathet Cardiovasc Diagn (1995) 1.91

Statin effects beyond lipid lowering--are they clinically relevant? Eur Heart J (2003) 1.90

Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet (1972) 1.90

Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart (2009) 1.89

A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J Exp Med (1986) 1.87

Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med (1979) 1.87

Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation (1994) 1.86

Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85

Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol (1984) 1.85

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85

Exercise: effects on physical functional performance in independent older adults. J Gerontol A Biol Sci Med Sci (1999) 1.83

A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82

The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol (1992) 1.79

Natriuretic peptide system in human heart failure. Circulation (1993) 1.79

Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab (2005) 1.78

Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. Circulation (1994) 1.76

The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res (2000) 1.75

Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation (1992) 1.75

Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke (1997) 1.74

Effects of a positron-emitting vanadium-48 nitinol stent on experimental restenosis in porcine coronary arteries: an injury-response study. Cardiovasc Radiat Med (2001) 1.72

Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1990) 1.72

Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J (2001) 1.72

Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut (2004) 1.72

Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc (1992) 1.70

Coronary artery stents. JAMA (2000) 1.70

Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med (2001) 1.70

Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart (2009) 1.70

Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study. Heart (2009) 1.69

Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest (1998) 1.68